Novocure: Using Physics to Fight Cancer - [Business Breakdowns, EP. 37]

Dec 1, 2021

Bill Doyle, Executive Chairman of Novocure, shares insights on the innovative approach his company is taking in cancer treatment. He highlights the use of tumor treating fields, a groundbreaking technology utilizing electrical fields to target cancer cells without harming healthy ones. Doyle discusses the slow evolution of cancer therapies, the importance of early detection, and the potential of combining emerging treatments like immunotherapy and mRNA. He also elaborates on the unique subscription model of Novocure that aims to enhance patient access and expand treatment options.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Early Detection

Current cancer detection relies on symptom presentation, often leading to late diagnosis.
Emerging blood-borne diagnostics offer promising earlier detection possibilities.

ANECDOTE

Novocure's Pioneering Technology

Yoram Palti, an expert in electrical phenomena's effects on tissue, pioneered tumor-treating fields.
This fourth modality uses electric fields to disrupt cancer cell division, offering a new approach to cancer treatment.

INSIGHT

Targeted Therapy

Tumor-treating fields target cancer cells by tuning frequencies to penetrate their membranes, disrupting division.
This targeted approach, similar to tuning a radio, minimizes harm to healthy cells.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

Today, we’re breaking down Novocure, a global oncology company that has pioneered a new approach to cancer treatment. For over 100 years, the tools used to fight cancer have largely remained unchanged, but there are promising signs of a renaissance and Novocure is at the vanguard of that charge.

To explain the state of cancer research and how the business has developed over the past twenty years, I’m joined by Bill Doyle – Novocure’s Executive Chairman. Please enjoy this breakdown of Novocure.

For the full show notes, transcript, and links to the best content to learn more, check out the episode page here.

-----

Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes.

Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.

Show Notes

[00:03:05] - [First question] - The current state of cancer treatment today writ large

[00:05:43] - What cancer is and how it becomes life threatening

[00:06:38] - Why uncontrolled cell growth is so bad

[00:07:27] - The main three ways we currently treat cancer

[00:11:29] - Whether or not there are targeted ways we can treat cancer like mRNA

[00:14:08] - How we’ve historically detected cancer and what future detection could look like

[00:17:12] - Death rates of cancer in the US annually and the business side as it stands today

[00:18:20] - Key players in the cancer treatment space that serve patients

[00:19:13] - The pioneering technology that Novocure created to treat cancer

[00:22:38] - The mechanism that allows their tech to target the right cells

[00:25:35] - Overview of the actual procedure that takes place with their therapy

[00:28:36] - The impact and results of their new treatment method

[00:33:37] - A future where we can take this in a prophylactic and preventive sense

[00:34:44] - Why this approach to cancer treatment isn’t more widely known and accepted

[00:38:09] - Financials of Novocure and the opportunities it presents for their business

[00:43:10] - How they spend their R&D dollars and horizontal and vertical growth

[00:48:01] - Unique ways how they spend their revenue to scale their business

[00:51:05] - Biggest criticisms of the size and scope of Novocure

[00:52:18] - Broader business lessons learned while building a cancer treatment company

[00:55:23] - The future of healthcare more generally and what has him most excited